Harare, (New Ziana) – The PACMAN project, a collaborative initiative addressing animal-borne diseases, is making remarkable progress in disease surveillance and control, holding great potential for enhanced health for both humans and animals.

On November 16, 2020, the French Agency for Development (AFD) and the French Agricultural Research Centre for International Development (CIRAD) signed an agreement to develop the Zimbabwean agricultural sector’s biotechnology capacity, to strengthen the country’s surveillance and control system for animal, plant and zoonotic diseases.

The project, entitled PACMAN, started in November 2020 and will last three years.

Launched through a multi-partner initiative, PACMAN brings together expertise from local and international organizations, including the University of Zimbabwe, CIRAD, the AFD, the Institut de Recherche pour le developpement (IRD) and the Department of Veterinary Services (DVS).

A fascinating aspect of the research is the focus on Simian Immunodeficiency Virus (SIV) in monkeys.

Researchers have been testing green monkeys and baboons uncovering valuable insights into the virus’s behavior and potential risks to human life.

The commitment of the project to sustainability is what sets it apart as, rather than operating in isolation, the PACMAN builds upon previous initiatives, creating a continuous cycle of innovation.

As Head of the University of Zimbabwe Biotechnology platform, Dr Ellen Mwandiringana explained, “Each project gives birth to a new one, ensuring our progress is incremental and impactful.”

Through partnerships forged with the Parks and Wildlife Management Authority of Zimbabwe and conservation agencies, researchers can access critical samples and data, informing policy decisions that protect both human and animal health.

New Ziana